The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Generative Models for De Novo Drug Design
Abstract
Artificial intelligence (AI) is booming. Among various AI approaches, generative models have received much attention in recent years. Inspired by these successes, researchers are now applying generative model techniques to de novo drug design, which has been considered as the "holy grail" of drug discovery. In this Perspective, we first focus on describing models such as recurrent neural network, autoencoder, generative adversarial network, transformer, and hybrid models with reinforcement learning. Next, we summarize the applications of generative models to drug design, including generating various compounds to expand the compound library and designing compounds with specific properties, and we also list a few publicly available molecular design tools based on generative models which can be used directly to generate molecules. In addition, we also introduce current benchmarks and metrics frequently used for generative models. Finally, we discuss the challenges and prospects of using generative models to aid drug design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hochreiter, S., & Schmidhuber, J. (1997) · Neural Computation · doi:10.1162/neco.1997.9.8.1735 · Cited by 102,318
Neural networks and physical systems with emergent collective computational abilities.
Hopfield, J. J. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.8.2554 · Cited by 19,270
Unsupervised representation learning with deep convolutional generative adversarial networks
Radford, A., Metz, L., & Chintala, S. (2015) · arXiv · doi:10.48550/arxiv.1511.06434 · Cited by 12,235
Empirical Evaluation of Gated Recurrent Neural Networks on Sequence Modeling
Chung, J., Gulcehre, C., Cho, K., & Bengio, Y. (2014) · arXiv · doi:10.48550/arxiv.1412.3555 · Cited by 11,008
Learning Deep Architectures for AI
Bengio, Y. (2009) · Foundations and Trends® in Machine Learning · doi:10.1561/2200000006 · Cited by 9,239
Reinforcement Learning: A Survey
Kaelbling, L. P., Littman, M. L., & Moore, A. W. (1996) · Journal of Artificial Intelligence Research · doi:10.1613/jair.301 · Cited by 8,972
Conditional Generative Adversarial Nets
Mirza, M., & Osindero, S. (2014) · arXiv · doi:10.48550/arxiv.1411.1784 · Cited by 8,863
Transformers: State-of-the-Art Natural Language Processing
Wolf, T., Debut, L., Sanh, V., Chaumond, J., Delangue, C., Moi, A., Cistac, P., Rault, T., Louf, R., Funtowicz, M., et al. (2020) · Proceedings of the 2020 Conference on Empirical Methods in Natural Language Processing: System Demonstrations · doi:10.18653/v1/2020.emnlp-demos.6 · Cited by 8,741
Weininger, D. (1988) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci00057a005 · Cited by 7,436 · cited 1×
“SMILES was developed by Weininger in the late 1980s, 62 which is a formal grammar that explicitly describes molecular structures using ASCII strings.”
PubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436
Recurrent neural network based language model
Mikolov, T., Karafiát, M., Burget, L., Černocký, J., & Khudanpur, S. (2010) · Interspeech 2010 · doi:10.21437/interspeech.2010-343 · Cited by 5,390
WaveNet: a generative model for raw audio
Oord, A. V. D., Dieleman, S., Zen, H., Simonyan, K., Vinyals, O., Graves, A., Kalchbrenner, N., Senior, A., & Kavukcuoglu, K. (2016) · arXiv · doi:10.48550/arxiv.1609.03499 · Cited by 4,911
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Generating Sentences from a Continuous Space
Bowman, S. R., Vilnis, L., Vinyals, O., Dai, A., Jozefowicz, R., & Bengio, S. (2016) · Proceedings of The 20th SIGNLL Conference on Computational Natural Language Learning · doi:10.18653/v1/k16-1002 · Cited by 2,061
Analyzing Learned Molecular Representations for Property Prediction
Yang, K., Swanson, K., Jin, W., Coley, C., Eiden, P., Gao, H., Guzman-Perez, A., Hopper, T., Kelley, B., Mathea, M., et al. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00237 · Cited by 1,923
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
Deep learning enables rapid identification of potent DDR1 kinase inhibitors
Zhavoronkov, A., Ivanenkov, Y. A., Aliper, A., Veselov, M. S., Aladinskiy, V. A., Aladinskaya, A. V., Terentiev, V. A., Polykovskiy, D. A., Kuznetsov, M. D., Asadulaev, A., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0224-x · Cited by 1,573
Enumeration of 166 Billion Organic Small Molecules in the Chemical Universe Database GDB-17
Ruddigkeit, L., van Deursen, R., Blum, L. C., & Reymond, J.-L. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300415d · Cited by 1,505
Hybrid computing using a neural network with dynamic external memory
Graves, A., Wayne, G., Reynolds, M., Harley, T., Danihelka, I., Grabska-Barwińska, A., Colmenarejo, S. G., Grefenstette, E., Ramalho, T., Agapiou, J., et al. (2016) · Nature · doi:10.1038/nature20101 · Cited by 1,412
GuacaMol: Benchmarking Models for de Novo Molecular Design
Brown, N., Fiscato, M., Segler, M. H. S., & Vaucher, A. C. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00839 · Cited by 895
Molecular Sets (MOSES): A Benchmarking Platform for Molecular Generation Models
Polykovskiy, D., Zhebrak, A., Sanchez-Lengeling, B., Golovanov, S., Tatanov, O., Belyaev, S., Kurbanov, R., Artamonov, A., Aladinskiy, V., Veselov, M., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.565644 · Cited by 849
Estimation of the size of drug-like chemical space based on GDB-17 data
Polishchuk, P. G., Madzhidov, T. I., & Varnek, A. (2013) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-013-9672-4 · Cited by 619
Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., & Zhavoronkov, A. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00346 · Cited by 587
MolGAN: An implicit generative model for small molecular graphs
De Cao, N., & Kipf, T. (2018) · arXiv · doi:10.48550/arxiv.1805.11973 · Cited by 442
Molecular generative model based on conditional variational autoencoder for de novo molecular design
Lim, J., Ryu, S., Kim, J. W., & Kim, W. Y. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0286-7 · Cited by 421
Application of Generative Autoencoder in De Novo Molecular Design
Blaschke, T., Olivecrona, M., Engkvist, O., Bajorath, J., & Chen, H. (2018) · Molecular Informatics · doi:10.1002/minf.201700123 · Cited by 411
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
Entangled Conditional Adversarial Autoencoder for de Novo Drug Discovery
Polykovskiy, D., Zhebrak, A., Vetrov, D., Ivanenkov, Y., Aladinskiy, V., Mamoshina, P., Bozdaganyan, M., Aliper, A., Zhavoronkov, A., & Kadurin, A. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00839 · Cited by 278 · cited 4×
“104 Me ́ ndez-Lucio et al. 105 reported a generative model which links systems biology to molecular design.”
InfluentialAssessing the impact of generative AI on medicinal chemistry
Walters, W. P., & Murcko, M. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0418-2 · Cited by 262
Cited by
Bandi, A., Adapa, P. V. S. R., & Kuchi, Y. E. V. P. K. (2023) · Future Internet · doi:10.3390/fi15080260 · Cited by 638
Machine Learning Methods for Small Data Challenges in Molecular Science
Dou, B., Zhu, Z., Merkurjev, E., Ke, L., Chen, L., Jiang, J., Zhu, Y., Liu, J., Zhang, B., & Wei, G.-W. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00189 · Cited by 499
Self-citationIntegrating QSAR modelling and deep learning in drug discovery: the emergence of deep QSAR
Tropsha, A., Isayev, O., Varnek, A., Schneider, G., & Cherkasov, A. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00832-0 · Cited by 397
Attention is all you need: utilizing attention in AI-enabled drug discovery
Zhang, Y., Liu, C., Liu, M., Liu, T., Lin, H., Huang, C.-B., & Ning, L. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad467 · Cited by 377
Computer especially AI-assisted drug virtual screening and design in traditional Chinese medicine
Lin, Y., Zhang, Y., Wang, D., Yang, B., & Shen, Y.-Q. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154481 · Cited by 107
Metadata
- Authors
- Tong, X., Liu, X., Tan, X., Li, X., Jiang, J., Xiong, Z., Xu, T., Jiang, H., Qiao, N., & Zheng, M.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-09-17
- Volume
- 64
- Issue
- 19
- Pages
- 14011-14027
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3201230437
- Cited by
- 233
- References
- 31
- FWCI
- 15.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.